XIST
HEKTS
Market cap651mUSD
Nov 12, Last price
3.28TRY
Name
Hektas Ticaret TAS
Chart & Performance
P/E
—
P/S
5.68
EPS
—
Div Yield, %
—
Shrs. gr., 5y
29.27%
Rev. gr., 5y
46.04%
Revenues
4.87b
-19.41%
Net income
-2.73b
L+210.48%
CFO
3.97b
+168.95%
Dividend
Dec 02, 20190.0262 TRY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hektas Ticaret T.A.S. produces, imports, and markets agricultural and veterinary pesticides and fertilizers in Turkey. Its crop protection products include fungicides, herbicides, insecticides, acaricides, biological insecticides, fumigants, nematicides and soil fumigants, plant growth regulators, winter struggle medicines and summer oils, and spread adhesives. The company also offers leaf fertilizers, organ minerals, drip irrigation, and other products; and tomato seeds. In addition, it provides antibacterial, vitamin and mineral, feed additive, anti-inflammatory, and anti-parasite health products for animal; poultry health products; and pet care products and pet foods. Hektas Ticaret T.A.S. was founded in 1956 and is headquartered in Gebze, Turkey.
Valuation
Title TRY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||